Company intelligence / Profile preview

Solco Healthcare

Somerset, New Jersey, United States

Ownership: Private
Employees: ~309
Development stage: Other

Overview

Solco Healthcare markets 23–56 generic small-molecule drugs in a variety of therapeutic areas, with over 35–40 additional products pending FDA approval. Their drugs are manufactured in GMP-compliant facilities in the US and China. No proprietary clinical trials; performance measured via regulatory approval and commercial success

Therapeutic areas: PsychiatryInfectious DiseasesCardiovascularOtherNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Strategic manufacturing partnerships with Prinston PharmaceuticalZhejiang Huahai Pharmaceutical

Beyond the preview

Go deeper on Solco Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solco Healthcare.

Explore the full profile